GS
George L Sing
Director

George L Sing insider trades: Regeneron Pharmaceuticals (REGN) stock buys and sales

Director, Regeneron Pharmaceuticals Last trade Nov 2, 2026 63 Form 4 filings
$20.4M
Sold, last 12 months
1 sale
$0
Bought, last 12 months
0 buys
58
Open-market trades
since 2009
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where George reports to the SEC

Open-market buys and sales

58 trades reported on SEC Form 4, newest first

DateStockTypeValue
Nov 2, 2026REGN↓ Sell$20.4M
Feb 26, 2024REGN↓ Sell$993K
Feb 23, 2024REGN↓ Sell$3.4M
Feb 9, 2024REGN↓ Sell$950K
Feb 28, 2022REGN↓ Sell$2.5M
Nov 22, 2021REGN↓ Sell$2.0M
Nov 18, 2021REGN↓ Sell$6.5M
Nov 16, 2021REGN↓ Sell$488K
Aug 30, 2021REGN↓ Sell$673K
Aug 30, 2021REGN↓ Sell$268K
Aug 30, 2021REGN↓ Sell$202K
Aug 16, 2021REGN↓ Sell$628K
Aug 16, 2021REGN↓ Sell$444K
Aug 13, 2021REGN↓ Sell$2.2M
Aug 11, 2021REGN↓ Sell$186K
Aug 10, 2021REGN↓ Sell$4.0M
Aug 6, 2021REGN↓ Sell$214K
Aug 31, 2020REGN↓ Sell$6.1M
Aug 25, 2020REGN↓ Sell$19.9M
Aug 25, 2020REGN↓ Sell$612K
Aug 24, 2020REGN↓ Sell$36.9M
Jul 7, 2020REGN↓ Sell$4.9M
Jul 7, 2020REGN↓ Sell$975K
Jul 7, 2020REGN↓ Sell$650K
Jul 7, 2020REGN↓ Sell$325K
Jun 29, 2020REGN↓ Sell$914K
Jun 29, 2020REGN↓ Sell$608K
Jun 29, 2020REGN↓ Sell$305K
May 29, 2020REGN↓ Sell$589K
May 29, 2020REGN↓ Sell$587K
May 13, 2020REGN↓ Sell$2.9M
May 11, 2020REGN↓ Sell$173K
May 11, 2020REGN↓ Sell$173K
May 11, 2020REGN↓ Sell$144K
Feb 26, 2020REGN↓ Sell$1.1M
Feb 26, 2020REGN↓ Sell$453K
Feb 26, 2020REGN↓ Sell$363K
Feb 26, 2020REGN↓ Sell$272K
Jan 2, 2020REGN↓ Sell$5.6M
May 10, 2018REGN↓ Sell$5.7M
Nov 18, 2015REGN↓ Sell$1.7M
Nov 18, 2015REGN↓ Sell$290K
May 27, 2015REGN↓ Sell$2.6M
Feb 20, 2015REGN↓ Sell$6.3M
Feb 21, 2014REGN↓ Sell$5.1M
Feb 14, 2014REGN↓ Sell$4.9M
Nov 26, 2013REGN↓ Sell$3.0M
May 10, 2013REGN↓ Sell$1.4M
Nov 29, 2012REGN↓ Sell$925K
Nov 16, 2012REGN↓ Sell$760K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other REGN insiders

Open-market trades in the last 12 months

About George L Sing's insider trades

George L Sing is a director at Regeneron Pharmaceuticals (REGN). Since Nov 13, 2009, George has reported 4 open-market purchases worth $448K and 54 sales worth $167.3M on SEC Form 4. In the last 12 months: 1 sale ($20.4M).

Their filings also include option exercises (28 filings), grants and awards (21 filings), shares withheld for taxes (3 filings), gifts (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every REGN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.